Latest Director Participation News

Findi Limited has extended the closing date of its offer to 19 March 2026 and updated details following a $25 million institutional placement. The company’s share capital structure and financial position have been revised, with key changes including director participation and lead manager incentives.

EVE Health Group has raised $0.9 million to advance its pharmaceutical reformulation programs targeting global markets worth over US$30 billion. The funding will support development of improved delivery technologies for medicines nearing patent expiry.

Spenda Limited has successfully raised $1.4 million through a private placement, supported by both new and existing sophisticated investors, including key directors. The funds will fuel the company’s commercialisation efforts and strengthen its working capital position.

Golden Mile Resources has raised $730,000 through a discounted private placement to fund accelerated exploration at its promising Aurora and Yuinmery gold projects.

Greenwing Resources has completed a $5.5 million equity raising, positioning itself to advance lithium, polymetallic, and graphite projects across Madagascar and Argentina. The capital raise enjoys strong backing from existing shareholders and directors, including the Managing Director.

Magnetite Mines Limited has announced a renounceable rights issue aiming to raise up to $3.92 million to fund exploration across its South Australian tenements and advance the Razorback Iron Ore Project, recently awarded Major Project Status.

Rincon Resources has successfully raised $3.1 million to fund an expanded drilling campaign at its promising Telfer South Gold-Copper Project, following the discovery of a significantly larger mineralised zone at the Hasties Prospect.

Provaris Energy reported a 59% increase in its half-year loss to $2.09 million, driven by higher project development costs amid progress in hydrogen and carbon capture technologies. The company raised over $3.5 million in capital and is advancing key milestones for its hydrogen shipping and liquid CO2 tank projects.

Bhagwan Marine reports a sharp 67% drop in net profit for the half-year to December 2025, while announcing a transformative $130 million acquisition of Riverside Marine Holdings.

Anatara Lifesciences reports a significantly reduced net loss for H1 FY2026, driven by promising pre-clinical results in its anti-obesity program and a successful $1.2 million capital raise. The company also highlights positive Phase II trial outcomes for its gastrointestinal health product GaRP.

Celsius Resources has raised A$9.3 million through a well-supported institutional placement, strengthening its balance sheet to advance the financing and early development of its flagship MCB copper-gold project in the Philippines.

BPH Energy Ltd reported a half-year net loss of $925,691, weighed down by investment write-downs and associate losses, while raising $1.2 million to fund exploration and development. The company’s future hinges on a Federal Court review of a critical offshore permit held by investee Advent Energy.